These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29109911)

  • 41. Significant association of the
    Shi T; Jiang R; Wang P; Xu Y; Yin S; Cheng X; Zang R
    Onco Targets Ther; 2017; 10():4841-4851. PubMed ID: 29042795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
    Mascarenhas C; Lambe M; Bellocco R; Bergfeldt K; Riman T; Persson I; Weiderpass E
    Int J Cancer; 2006 Dec; 119(12):2907-15. PubMed ID: 16998830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
    Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
    Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic polymorphisms in
    Si W; Kang S; Sun H; Chen J; Cao S; Li Y
    Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.
    Wang K; Guan C; Fang C; Jin X; Yu J; Zhang Y; Zheng L
    Oncol Lett; 2018 Apr; 15(4):4457-4462. PubMed ID: 29541214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis.
    Yang J; Jin Y; Cheng S; Wang C; Zhang N; Huang S; Zhao Y; Wang Y
    J Ovarian Res; 2021 Aug; 14(1):106. PubMed ID: 34404438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer.
    Zeng Y; Li TL; Zhang HB; Deng JL; Zhang R; Sun H; Wan ZR; Liu YZ; Zhu YS; Wang G
    Pharmacogenomics; 2019 Feb; 20(3):179-188. PubMed ID: 30672383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population.
    Zhang HB; Zeng Y; Li TL; Wang G
    Genomics; 2020 May; 112(3):2510-2515. PubMed ID: 32045670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-532-5p is a prognostic marker and suppresses cells proliferation and invasion by targeting TWIST1 in epithelial ovarian cancer.
    Wei H; Tang QL; Zhang K; Sun JJ; Ding RF
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5842-5850. PubMed ID: 30280764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
    Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
    Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of Gab1 Is Associated with Poor Prognosis of Patients with Epithelial Ovarian Cancer.
    Hu L; Liu R
    Tohoku J Exp Med; 2016 Jul; 239(3):177-84. PubMed ID: 27302321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes.
    Li Y; Zhang HL; Kang S; Zhou RM; Wang N
    Gynecol Oncol; 2017 Jan; 144(1):140-145. PubMed ID: 27836206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ABO Blood Type Has No Impact on Survival in Patients with Epithelial Ovarian Cancer.
    Wang L; Yang Z; Liu Y; Wang YN; Guo JY; Wu QJ; Gong TT
    J Cancer; 2018; 9(23):4334-4340. PubMed ID: 30519337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer.
    Wang X; Meng X; Li H; Liu W; Shen S; Gao Z
    Clin Transl Oncol; 2014 Nov; 16(11):954-8. PubMed ID: 24696291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rs3802278 in 3'-UTR of
    Zeng F; Liu Y; Ouyang Q; Sun Z; Zhang K; Li X; Liu Y
    J Chemother; 2021 Dec; 33(8):564-569. PubMed ID: 34029511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
    Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
    Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
    Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional genetic variants of
    Li H; Chen L; Tong X; Dai H; Shi T; Cheng X; Sun M; Chen K; Wei Q; Wang M
    J Cancer; 2020; 11(23):6850-6860. PubMed ID: 33123276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.